REQUEST A DEMO
Total
USD $0.00
Search more companies

Ci Naturmega S.A. (Colombia)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Ci Naturmega S.A. Profile Updated: December 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Ci Naturmega S.A. is a company based in Colombia, with its head office in Barranquilla. The company operates in the Pharmaceutical Preparation Manufacturing sector. The company was established on October 12, 2006. The total number of employees is currently 126 (2023). The latest financial highlights indicate a net sales revenue increase of 50.29% in 2023. During that time, Ci Naturmega S.A.’s total assets grew by 19.26%. In 2023, Ci Naturmega S.A.’s net profit margin decreased by 1.54%.

Headquarters
Cll 80 78 B 201
Barranquilla; Atlantico;

Contact Details: Purchase the Ci Naturmega S.A. report to view the information.

Basic Information
Total Employees:
Purchase the Ci Naturmega S.A. report to view the information.
Outstanding Shares:
Purchase the Ci Naturmega S.A. report to view the information.
Incorporation Date:
October 12, 2006
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Member of the Board of Directors
Purchase this report to view the information.
Member of the Board of Directors
Purchase this report to view the information.
Member of the Board of Directors
Purchase this report to view the information.
Alternate Legal Representative
Company Performance
Financial values in the chart are available after Ci Naturmega S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
50.29%
Total operating revenue
50.37%
Operating profit (EBIT)
40.97%
EBITDA
35.46%
Net Profit (Loss) for the Period
19.63%
Total assets
19.26%
Total equity
78.72%
Operating Profit Margin (ROS)
-0.98%
Net Profit Margin
-1.54%
Return on Equity (ROE)
-8.19%
Debt to Equity Ratio
-35.66%
Quick Ratio
0.17%
Cash Ratio
0.04%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?